U.S. market Closed. Opens in 1 day 7 hours 43 minutes

NRBO | NeuroBo Pharmaceuticals, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-31
RevenueN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Cost of RevenueN/A28.00K72.00K67.00K17.00KN/AN/AN/AN/AN/A
Gross ProfitN/A-28.00K-72.00K-67.00K-17.00KN/AN/AN/AN/AN/A
Operating Expenses15.89M11.42M15.30M29.72M20.18M22.80M33.12M14.70M7.17M266.00K
Selling, General & Admin6.73M8.64M8.75M7.85M2.70M8.49M10.44M5.96M3.18M214.00K
Research & Development9.16M2.78M6.55M21.87M17.48M14.31M22.69M8.74M3.99M52.00K
Other Operating ExpensesN/A-83.00KN/A-1.00K12.15M-178.00K10.44MN/AN/AN/A
Operating Income-15.89M-19.63M-15.30M-29.72M-20.18M-22.80M-33.12M-14.70M-8.08M-266.00K
Other Expenses / Income3.42M5.66M14.00K38.00K-1.14M-43.00K-291.00K110.00K-953.00K-54.00K
Before Tax Income-12.47M-13.97M-15.28M-29.68M-21.31M-23.64M-33.41M-14.59M-9.03M-320.00K
Income Tax ExpensesN/A-7.85M-62.00K-85.00K1.12M654.00K286.00K-136.82K-146.00K55.00K
Net Income-12.47M-6.12M-15.22M-29.59M-22.43M-23.64M-33.41M-14.59M-9.03M-320.00K
Interest ExpensesN/A2.19MN/A39.00K22.00K654.00KN/AN/AN/AN/A
Basic Shares Outstanding5.07M321.70K96.43K67.57K21.77K141.71K13.80K7.75K7.07K7.07K
Diluted Shares Outstanding5.07M321.70K96.43K67.57K21.77K141.71K13.80K7.75K7.07K7.07K
EBITDA-15.88M-11.40M-15.21M-29.61M-21.17M-15.49M-33.09M-14.50M-6.07M-283.00K
EBITDA Margin0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
EBIT-12.47M-11.78M-15.28M-29.64M-21.29M-22.33M-33.13M-14.72M-9.18M-265.00K
EBIT Margin0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙